Methodology of EARLIMS Study: A Multi-Center, Open-Label, Non-Randomized, Parallel Group Clinical Trial To Assess the Efficacy of Fingolimod in Treatment-Naive Patients Versus Fingolimod in Patients Previously Treated with Interferons or Glatiramer Acetate, Based on the Presence of Relapses in Patients with Relapsing-Remitting Multiple Sclerosis (P04.126) | Publicación